Satoh, Jo
124  results:
Search for persons X
?
1

Adiponectin Paradox More Evident in Non-Obese Than in Obese..:

Satoh, Ken ; Nagasawa, Kan ; Takebe, Noriko...
Diabetes, Metabolic Syndrome and Obesity.  16 (2023)  - p. 201-212 , 2023
 
?
3

Diabetes Care Providers' Manual for Disaster Diabetes Care:

Satoh, Jo ; Yokono, Koichi ; Ando, Rie...
Journal of Diabetes Investigation.  10 (2019)  4 - p. 1118-1142 , 2019
 
?
4

Diabetes care providers' manual for disaster diabetes care:

Satoh, Jo ; Yokono, Koichi ; Ando, Rie...
Diabetology International.  10 (2019)  3 - p. 153-179 , 2019
 
?
5

Efficacy and safety of pemafibrate in people with type 2 di..:

Araki, Eiichi ; Yamashita, Shizuya ; Arai, Hidenori...
Diabetes, Obesity and Metabolism.  21 (2019)  7 - p. 1737-1744 , 2019
 
?
8

Aldose reductase inhibitor ranirestat significantly improve..:

Sekiguchi, Kenji ; Kohara, Nobuo ; Baba, Masayuki...
Journal of Diabetes Investigation.  10 (2018)  2 - p. 466-474 , 2018
 
?
 
?
10

Efficacy and safety of sitagliptin as compared with glimepi..:

Terauchi, Yasuo ; Yamada, Yuichiro ; Ishida, Hitoshi...
Diabetes, Obesity and Metabolism.  19 (2017)  8 - p. 1188-1192 , 2017
 
?
11

Association of Advanced Glycation End Products with coronar..:

Hangai, Mari ; Takebe, Noriko ; Honma, Hiroyuki...
Journal of Atherosclerosis and Thrombosis.  23 (2016)  10 - p. 1178-1187 , 2016
 
?
12

Efficacy and safety comparison of sitagliptin and glimepiri..:

Shihara, Nobuyuki ; Terauchi, Yasuo ; Ishida, Hitoshi...
Diabetes Research and Clinical Practice.  120 (2016)  - p. S130-S131 , 2016
 
?
 
1-15